Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerValsamo Anagnostou, Victor E. Velculescu, James R. White et al.|Nature Cancer|2020Cited by 207
<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Daniel S. Peeper, Alex van Vliet et al.|OncoImmunology|2022Cited by 33